-
Something wrong with this record ?
Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis
J. Panek, E. Koziolova, P. Stepanek, T. Etrych, O. Janouskova
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Doxorubicin analogs & derivatives pharmacokinetics MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Nanoparticles MeSH
- Drug Carriers * MeSH
- Optical Imaging methods MeSH
- Polymers MeSH
- Antineoplastic Agents pharmacokinetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Nanocarriers bearing anticancer drugs are promising candidates to improve the efficacy of cancer therapy and minimize side effects. The most potent cytostatics used in the treatment of various cancers are anthracyclines, e.g. doxorubicin or pirarubicin. Recently, polymer therapeutics carrying anthracyclines have been intensively studied. The precise characterization of in vitro nanocarrier biological behavior brings a better understanding of the nanocarrier characteristics and enables prediction of the behavior of the nanocarrier during in vivo application. Advanced fluorescence detection methods, e.g. fluorescence lifetime imaging microscopy (FLIM), were successfully exploited to describe the properties of various polymeric nano-systems and contributed to a complex view of anthracyclines' intracellular transport and DNA intercalation. Here, we report the application of a specific technique for processing FLIM images, called fluorescence pattern decomposition, to evaluate early events after doxorubicin or pirarubicin treatment of cells. Moreover, we characterized changes in the intracellular localization and release of the anthracyclines during the incubation of cells with polymer nanotherapeutics based on poly[N-(2-hydroxypropyl)-methacrylamide] (pHPMA).
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17020999
- 003
- CZ-PrNML
- 005
- 20190814100910.0
- 007
- ta
- 008
- 170623s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933423 $2 doi
- 035 __
- $a (PubMed)27762587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pánek, Jan, $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic $d 1955- $7 ola2003197902
- 245 10
- $a Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis / $c J. Panek, E. Koziolova, P. Stepanek, T. Etrych, O. Janouskova
- 520 9_
- $a Nanocarriers bearing anticancer drugs are promising candidates to improve the efficacy of cancer therapy and minimize side effects. The most potent cytostatics used in the treatment of various cancers are anthracyclines, e.g. doxorubicin or pirarubicin. Recently, polymer therapeutics carrying anthracyclines have been intensively studied. The precise characterization of in vitro nanocarrier biological behavior brings a better understanding of the nanocarrier characteristics and enables prediction of the behavior of the nanocarrier during in vivo application. Advanced fluorescence detection methods, e.g. fluorescence lifetime imaging microscopy (FLIM), were successfully exploited to describe the properties of various polymeric nano-systems and contributed to a complex view of anthracyclines' intracellular transport and DNA intercalation. Here, we report the application of a specific technique for processing FLIM images, called fluorescence pattern decomposition, to evaluate early events after doxorubicin or pirarubicin treatment of cells. Moreover, we characterized changes in the intracellular localization and release of the anthracyclines during the incubation of cells with polymer nanotherapeutics based on poly[N-(2-hydroxypropyl)-methacrylamide] (pHPMA).
- 650 _2
- $a protinádorové látky $x farmakokinetika $7 D000970
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a doxorubicin $x analogy a deriváty $x farmakokinetika $7 D004317
- 650 12
- $a nosiče léků $7 D004337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nanočástice $7 D053758
- 650 _2
- $a optické zobrazování $x metody $7 D061848
- 650 _2
- $a polymery $7 D011108
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Koziolová, Eva $7 _AN081673 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Štěpánek, Petr, $d 1952- $7 xx0027070 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Etrych, Tomáš $7 xx0068504 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Janouskova, O. $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, Suppl. 2 (2016), s. S217-S224
- 773 0_
- $t Recent achievements from Otto Wichterle Innovation Centre of Polymeric Materials and Biocev Research Projects $x 1802-9973 $g Roč. 65, Suppl. 2 (2016), s. S217-S224 $w MED00196542
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170623 $b ABA008
- 991 __
- $a 20190814101137 $b ABA008
- 999 __
- $a ok $b bmc $g 1236295 $s 981872
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c Suppl. 2 $d S217-S224 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2016 $b 65 $c Suppl. 2 $d S217-S224 $i 1802-9973 $m Recent achievements from Otto Wichterle Innovation Centre of Polymeric Materials and Biocev Research Projects $x MED00196542
- LZP __
- $b NLK118 $a Pubmed-20170623